Intercept Offloads Ex-US Business To Advanz, May Be Doubling Down On NASH In US

 
• By Joseph Haas
  
International deal
Intercept dealt ex-US rights to Ocaliva to Advanz Pharma • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business